NEW BRUNSWICK, N.J.,
June 22, 2016 /PRNewswire/
-- Johnson & Johnson (NYSE: JNJ) today announced that
Louise Mehrotra, Vice President of
Investor Relations for Johnson & Johnson, will retire in
January 2017, after a transition
period with her successor. Louise first joined the Johnson &
Johnson Family of Companies in 1980, and has led Investor Relations
for more than 10 years.
"Louise has been a constant advocate for transparency and
credibility in our financial communications, a trusted advisor to
company management, and her commitment to excellence has led to the
development of a best-in-class IR team," said Dominic J. Caruso, Executive Vice President,
Chief Financial Officer of Johnson & Johnson. "We sincerely
thank her for more than 35 years of service, and for her leadership
in helping develop a strong and diverse Finance organization at
Johnson & Johnson."
Joseph Wolk will replace Mehrotra
as Vice President, Investor Relations, effective August 1. Wolk will continue to report to
Dominic Caruso.
"Joe is a proven leader in our Finance organization, and we are
confident he will continue our commitment to transparent and
credible engagement with the investment community. His cross-sector
expertise, prudent financial management and focus on talent
development will ensure the investor relations function at Johnson
& Johnson remains best-in-class," said Caruso.
Wolk was previously Vice President, Group Finance for the
Pharmaceuticals Group of Johnson & Johnson, where he provided
finance leadership, supporting Worldwide Chairman, Pharmaceuticals
Joaquin Duato, and Chief Scientific Officer Paul Stoffels, as a member of the
Pharmaceuticals Group Operating Committee. Prior to that role, he
held other finance leadership positions at Johnson & Johnson as
Vice President of Finance for the Medical Devices Global Supply
Chain, and as Chief Financial Officer of the North America
Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc.,
as well as U.S. Pricing Strategy and Compliance. Wolk joined
Johnson & Johnson in 1998 as a Finance Manager in the
Ortho-McNeil Pharmaceutical organization.
Prior to joining Johnson & Johnson, Wolk held multiple
positions of increasing responsibility at Ametek, Inc. He holds a
Bachelor of Science degree in Finance from St. Joseph's University,
where he currently serves on the Haub School of Business Board of
Visitors, and he also holds a Juris Doctor degree from Temple University School of Law and is a Certified
Public Accountant.
For a complete list of Johnson & Johnson Investor Relations
contacts, please visit www.investor.jnj.com.
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the
people of Johnson & Johnson. We embrace research and
science - bringing innovative ideas, products and services to
advance the health and well-being of people. Our approximately
127,500 employees at more than 250 Johnson &
Johnson operating companies work with partners in health care
to touch the lives of over a billion people every day, throughout
the world.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/johnson--johnson-announces-retirement-of-louise-mehrotra-and-appointment-of-joseph-wolk-as-vice-president-of-investor-relations-300288398.html
SOURCE Johnson & Johnson